Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Meta-analysis on the entomological effects of differentially treated ITNs in a multi-site experimental hut study in sub-Saharan Africa.
Lissenden, N; BRADLEY, J; Menze, B; Wondji, C; Edi, C; Koudou, B; N'Guessan, R; Bayili, K; Diabaté, A; Mbewe, N; Emidi, B; Mosha, J; Manjurano, A; Small, G; Oumbouke, W; Moore, SJ; Nimmo, D; Snetselaar, J;
2025
Malaria journal, (2025).24 1 10.1186/s12936-025-05264-2.
Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context.
Diawara, H; GRANT, J; Dicko, A; Traore, S; Issiaka, D; Koita, F; Datoo, M; Sylla, M; Dicko, AB; Sagara, I; CHANDRAMOHAN, D; Hill, AV; GREENWOOD, B; WEBSTER, J;
2025
BMJ global health, (2025).10 2 10.1136/bmjgh-2024-015524.
Drug resistance-associated mutations in Plasmodium UBP-1 disrupt its essential deubiquitinating activity.
Smith, CJ; Eavis, H; Briggs, C; Henrici, R; Karpiyevich, M; Ansbro, MR; Hoshizaki, J; Van der Heden van Noort, GJ; Ascher, DB; SUTHERLAND, CJ; Lee, MC S; Artavanis-Tsakonas, K;
2025
The Journal of biological chemistry, (2025).301 3 10.1016/j.jbc.2025.108266.
Genetically attenuated parasites show promise as a next-generation malaria vaccine.
HAFALLA, JC R; Borrmann, S; Matuschewski, K;
2025
Trends in parasitology, (2025).41 2 10.1016/j.pt.2024.12.015.
Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial.
Afolabi, MO; Adu-Gyasi, D; PAINTAIN, L; Tawiah, T; ALI, MS; GREENWOOD, B; ASANTE, KP;
2025
Tropical medicine & international health, (2025).30 1 10.1111/tmi.14062.
Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial.
AFOLABI MBBS, MPH, PHD, FWACP, FHEA, FFPH, M; Adu-Gyasi, D; PAINTAIN, L; Tawiah, T; ALI, MS; GREENWOOD, B; Asante, KP;
2025
Trop Med Int Health, (2025).30, 10.1111/tmi.14062.
Community benefits of mass distribution of three types of dual-active-ingredient long-lasting insecticidal nets against malaria prevalence in Tanzania: evidence from a 3-year cluster-randomized controlled trial.
Lukole, EA; COOK, J; Mosha, JF; MATOWO, NS; Kulkarni, MA; Mallya, E; Aziz, T; Martin, J; ROWLAND, M; KLEINSCHMIDT, I; Manjurano, A; Mosha, FW; Protopopoff, N;
2025
BMC public health, (2025).25 1 10.1186/s12889-025-21586-x.
The R21/Matrix-M malaria vaccine: questions remain - Author's reply.
Datoo, MS; Hill, AV S; BEAUMONT, E; BRADLEY, J;
2025
Lancet (London, England), (2025).405 10475 10.1016/s0140-6736(24)02780-6.
Incorporating Community Case Management in Risk-Based Surveillance for Malaria Elimination in the Dominican Republic.
BYRNE, I; Nelli, L; Ureña, K; Désir, L; Hilario Rodriguez, C; Michelén Ströfer, N; Lana, JT; Noland, GS; Tejada Beato, MD J; Cruz Raposo, JL; DRAKELEY, C; Hamre, KE S; Stresman, G;
2025
The American journal of tropical medicine and hygiene, (2025).112 4 10.4269/ajtmh.24-0404.
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Amen, A; Yoo, R; Fabra-García, A; Bolscher, J; STONE, WJ R; Bally, I; Dergan-Dylon, S; Kucharska, I; De Jong, RM; De Bruijni, M; Bousema, T; King, CR; MacGill, RS; Sauerwein, RW; Julien, J-P; Poignard, P; Jore, MM;
2025
eLife, (2025).13, 10.7554/elife.97865.3.